University Hospital of Cleveland

Cleveland, Ohio 44106

5 studies enrolling now · 27 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Solid Tumor, Advanced Solid Tumors, Amyloidosis, Bipolar Disorder, Colorectal Neoplasms, Cystic Fibrosis, Cystic Fibrosis (CF), Depressive Disorder, Major, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• SW-682 in Advanced Solid Tumors — Recruiting now
• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• Study With [225Ac]Ac-FL-020 in mCRPC Participants — Recruiting now
• A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis — Running, not enrolling
• Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta — Running, not enrolling
• Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer — Running, not enrolling
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide — Completed
• A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Completed
• A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS — Stopped early
• A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients — Completed
• Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) — Stopped early
• Standardized Treatment of Pulmonary Exacerbations II — Completed
• A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm — Completed
• Electrical Activation of The Diaphragm for Ventilatory Assist — Completed
• A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT) — Completed
• A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer — Stopped early
• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma — Completed
• A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients — Completed
• Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease — Completed
• Rituximab to Treat Severe Hemophilia A — Completed
• REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management — Completed
• Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) — Stopped early
• Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome — Stopped early
• Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness — Stopped early
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children — Stopped early